Navigation Links
MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
Date:8/20/2013

MARIETTA, Ga., Aug. 20, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Prospective, Randomized, Blinded, Comparative Study of Injectable Micronized Dehydrated Amniotic/Chorionic Membrane Allograft for Plantar Fasciitis—A Feasibility Study" has been electronically published in the journal, Foot & Ankle International. The study publication was authored by Charles M. Zelen, DPM, Attila Poka, MD, and James Andrews, MD. The hard copy is scheduled to be published in the October 2013 edition of Foot & Ankle International. The electronic publication of the study is available at http://fai.sagepub.com/content/early/recent.

The randomized clinical trial examined the efficacy of dehydrated human amnion/chorion membrane (dHACM) injection as a treatment for the inflammation associated with chronic refractory plantar fasciitis. The study determined that this injection for plantar fasciitis can reduce inflammation and promote healing and may be an alternative to surgical intervention. "In summary, this RCT concluded that patients with chronic/refractory plantar fasciitis randomized to receive a single-dose injection of AmnioFix® experienced significant improvement in symptoms and increased function within one week of injection, with continued improvement over the eight-week study period," said Parker H. Petit, Chairman and CEO.

"This is our first randomized control trial (RCT) conducted on our amnion allograft use in plantar fasciitis. This degenerative condition is one of the most common
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
4. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
5. MiMedx Group Announces 2011 Results
6. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
7. MiMedx Exceeds Revenue Goal for First Quarter of 2012
8. MiMedx Group Announces Record First Quarter Results
9. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
10. MiMedx Group Announces Record Second Quarter Results
11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YORK , April 21, 2015 AbilTo, ... today that its abstract submission has been accepted as ... Association,s (ADA) annual meeting taking place on June 5-6, 2015 ... According to the American Diabetes Association, the cost ... was $245 billion. As a result of increased inpatient, ...
(Date:4/21/2015)... April 21, 2015 Immune Pharmaceuticals Inc., or ... of Directors has elected Rene-Pierre Azria as ... Pricing Committee, with oversight on strategic and financial transactions. ... Audit Committee, the Compensation Committee and the Corporate Governance ... Azria commented: "I have a long-time interest in Life ...
(Date:4/21/2015)...  Novogen Limited (ASX:NRT; NASDAQ: NVGN ) ... it has entered into definitive agreements today to ... one attaching 6-month option and half of one ... to institutional investors in the United ... aggregate gross proceeds of approximately AU$15,500,000 ("Placement"). The ...
(Date:4/21/2015)... Thornton Cleveleys (UK) (PRWEB) April 21, 2015 ... PEEK* technology and its clinical applications will ... Meeting. Participants include engineers, scientists, regulators and ... worldwide. The meeting is sponsored by Invibio ... PEEK polymer-based biomaterials, a specialist in manufacturing ...
Breaking Biology Technology:AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 2AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 62nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3
... like to be able to charge their cell phones ... A recent discovery made by UC San Diego engineers ... just this. In recent research, published in ... in the UCSD Department of Mechanical and Aerospace Engineering, ...
... Corporation (Nasdaq: OMER ) today announced unaudited financial results for ... ended September 30, 2009, Omeros reported a net loss of $3.9 ... of $7.4 million, or $2.54 per share, for the same period ... Company reported a net loss of $15.5 million, or $5.29 per ...
... , BETHESDA, Md., Nov. 19 Spherix Incorporated ... therapy, and a provider of technical and regulatory consulting services ... closed the previously reported $6.3 million registered direct placement to ... warrants to purchase up to 1,104,348 additional shares of its ...
Cached Biology Technology:Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... David J. Friedman, MD, a clinician and scientific investigator ... Biology Research at Beth Israel Deaconess Medical Center (BIDMC) ... Award (CSDA) from the Doris Duke Charitable Foundation. The ... into the genetic and environmental factors that lead to ...
... genus and species of hadrosaur (duck-billed) dinosaur the ... been named by scientists who expect the discovery to ... feature of Acristavus gagslarsoni , the name given ... the distinctive ornamentation common to later duck-billed relatives. ...
... devices have become as common as the stethoscope in patient,s ... test results, access diagnostic tools and take patient notes, all ... or using a flash drive. These mobile devices are ideal ... security risks to patient information. In less than ...
Cached Biology News:BIDMC scientist David J. Friedman, M.D., receives award from Doris Duke Charitable Foundation 2New duck-billed dinosaur gives scientists clues to evolution of head ornamentation and provinciality 2Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 2Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 3Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 4Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 5
... degradation is critical to the maintenance ... regulatory proteins as important and diverse ... heat shock and stress response, antigen ... and ion channels, cell cycle regulation, ...
... Nucleic acid hybridization Preparation ... mg BSA, 50 mg ficoll ... with 5 ml of water ... for molecular biology Density: 1.00 ...
... The Vibratome Company has joined forces with ... the Vibratome 800 Tissue Chopper. This tissue ... sections of tissue for metabolic experiments and ... irregular specimens available at biopsy or from ...
... EvoQuest Custom Peptide Services offer a ... meet your research needs. Services include: ... Peptide synthesis, purified product ... modifications (acetylation, amidation, biotinylation, fluorescein, myristylation, phosphorylation, ...
Biology Products: